California Public Employees Retirement System’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $140M | Buy |
224,269
+5,497
| +3% | +$3.74M | 0.08% | 167 |
|
|
2026
Q1 | $169M | Buy |
218,772
+17,682
| +9% | +$13.5M | 0.1% | 139 |
|
|
2025
Q4 | $155M | Sell |
201,090
-2,024
| -1% | -$1.37M | 0.09% | 152 |
|
|
2025
Q3 | $114M | Sell |
203,114
-111,602
| -35% | -$63.1M | 0.07% | 214 |
|
|
2025
Q2 | $165M | Sell |
314,716
-158,734
| -34% | -$88.6M | 0.11% | 159 |
|
|
2025
Q1 | $300M | Buy |
473,450
+109,954
| +30% | +$75.6M | 0.21% | 89 |
|
|
2024
Q4 | $259M | Sell |
363,496
-8,142
| -2% | -$6.83M | 0.17% | 105 |
|
|
2024
Q3 | $391M | Sell |
371,638
-5,291
| -1% | -$5.89M | 0.27% | 70 |
|
|
2024
Q2 | $396M | Sell |
376,929
-30,129
| -7% | -$29.2M | 0.29% | 66 |
|
|
2024
Q1 | $392M | Sell |
407,058
-5,449
| -1% | -$5.18M | 0.28% | 77 |
|
|
2023
Q4 | $362M | Sell |
412,507
-7,737
| -2% | -$6.37M | 0.28% | 73 |
|
|
2023
Q3 | $346M | Sell |
420,244
-138,520
| -25% | -$109M | 0.3% | 69 |
|
|
2023
Q2 | $401M | Sell |
558,764
-15,048
| -3% | -$11.6M | 0.34% | 61 |
|
|
2023
Q1 | $471M | Sell |
573,812
-39,264
| -6% | -$29.6M | 0.42% | 51 |
|
|
2022
Q4 | $442M | Sell |
613,076
-130,121
| -18% | -$96M | 0.38% | 55 |
|
|
2022
Q3 | $512M | Sell |
743,197
-22,686
| -3% | -$14.3M | 0.47% | 44 |
|
|
2022
Q2 | $453M | Sell |
765,883
-10,057
| -1% | -$6.54M | 0.42% | 58 |
|
|
2022
Q1 | $542M | Sell |
775,940
-7,472
| -1% | -$4.73M | 0.42% | 51 |
|
|
2021
Q4 | $495M | Sell |
783,412
-19,267
| -2% | -$11.8M | 0.33% | 64 |
|
|
2021
Q3 | $486M | Buy |
802,679
+6,929
| +0.9% | +$4.3M | 0.36% | 59 |
|
|
2021
Q2 | $444M | Buy |
795,750
+3,514
| +0.4% | +$1.78M | 0.33% | 66 |
|
|
2021
Q1 | $375M | Sell |
792,236
-36,387
| -4% | -$17.7M | 0.29% | 75 |
|
|
2020
Q4 | $400M | Sell |
828,623
-2,178
| -0.3% | -$1.18M | 0.31% | 73 |
|
|
2020
Q3 | $465M | Sell |
830,801
-7,197
| -0.9% | -$4.36M | 0.41% | 53 |
|
|
2020
Q2 | $523M | Buy |
837,998
+654,007
| +355% | +$371M | 0.52% | 36 |
|
|
2020
Q1 | $89.8M | Sell |
183,991
-10,434
| -5% | -$4.3M | 0.11% | 203 |
|
|
2019
Q4 | $73M | Buy |
194,425
+10,597
| +6% | +$3.57M | 0.07% | 308 |
|
|
2019
Q3 | $51M | Buy |
183,828
+50,756
| +38% | +$15M | 0.05% | 356 |
|
|
2019
Q2 | $41.7M | Sell |
133,072
-9,263
| -7% | -$3.08M | 0.05% | 363 |
|
|
2019
Q1 | $58.4M | Sell |
142,335
-3,478
| -2% | -$1.43M | 0.07% | 304 |
|
|
2018
Q4 | $54.5M | Sell |
145,813
-19,328
| -12% | -$7.07M | 0.08% | 279 |
|
|
2018
Q3 | $66.7M | Sell |
165,141
-12,294
| -7% | -$4.68M | 0.09% | 230 |
|
|
2018
Q2 | $61.2M | Sell |
177,435
-8,433
| -5% | -$2.64M | 0.08% | 231 |
|
|
2018
Q1 | $64M | Buy |
185,868
+929
| +0.5% | +$323K | 0.09% | 216 |
|
|
2017
Q4 | $69.5M | Buy |
184,939
+10,910
| +6% | +$4.42M | 0.09% | 216 |
|
|
2017
Q3 | $77.8M | Buy |
174,029
+1,429
| +0.8% | +$680K | 0.12% | 173 |
|
|
2017
Q2 | $84.8M | Buy |
172,600
+3,000
| +2% | +$1.31M | 0.14% | 149 |
|
|
2017
Q1 | $65.7M | Sell |
169,600
-6,700
| -4% | -$2.48M | 0.11% | 191 |
|
|
2016
Q4 | $64.7M | Buy |
176,300
+6,500
| +4% | +$2.47M | 0.11% | 192 |
|
|
2016
Q3 | $68.3M | Sell |
169,800
-15,700
| -8% | -$6.3M | 0.11% | 180 |
|
|
2016
Q2 | $64.8M | Sell |
185,500
-11,300
| -6% | -$4.35M | 0.1% | 194 |
|
|
2016
Q1 | $70.9M | Sell |
196,800
-12,300
| -6% | -$5.07M | 0.11% | 170 |
|
|
2015
Q4 | $114M | Buy |
209,100
+100
| +0% | +$54.2K | 0.18% | 111 |
|
|
2015
Q3 | $97.2M | Hold |
209,000
| – | – | 0.17% | 118 |
|
|
2015
Q2 | $107M | Buy |
209,000
+14,500
| +7% | +$7.08M | 0.16% | 121 |
|
|
2015
Q1 | $80.9M | Hold |
194,500
| – | – | 0.11% | 183 |
|
|
2014
Q4 | $80.9M | Sell |
194,500
-12,348
| -6% | -$4.86M | 0.11% | 183 |
|
|
2014
Q3 | $74.6M | Buy |
206,848
+7,047
| +4% | +$2.36M | 0.1% | 186 |
|
|
2014
Q2 | $56.4M | Sell |
199,801
-21,869
| -10% | -$6.48M | 0.08% | 250 |
|
|
2014
Q1 | $63.5M | Sell |
221,670
-12,684
| -5% | -$3.91M | 0.09% | 212 |
|
|
2013
Q4 | $65.3M | Buy |
234,354
+44,854
| +24% | +$12.9M | 0.09% | 205 |
|
|
2013
Q3 | $59.3M | Buy |
189,500
+3,069
| +2% | +$807K | 0.11% | 179 |
|
|
2013
Q2 | $41.9M | Buy |
+186,431
| New | +$43.4M | 0.08% | 236 |
|
Other funds holding REGN
California Public Employees Retirement System's REGN Position: Q2 2026 in Review
California Public Employees Retirement System increased its Regeneron Pharmaceuticals (REGN) stake by 2.5% in Q2 2026, buying an estimated $3.74M and bringing the position to 224,269 shares worth $140M. The position accounts for 0.08% of the portfolio, ranked #167.
California Public Employees Retirement System first reported a position in REGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $542M in Q1 2022. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- California Public Employees Retirement System held 224,269 shares of Regeneron Pharmaceuticals worth $140M as of Q2 2026.
- California Public Employees Retirement System bought 5,497 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $3.74M.
- Regeneron Pharmaceuticals made up 0.08% of California Public Employees Retirement System's portfolio in Q2 2026, its #167 holding.
- California Public Employees Retirement System first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- California Public Employees Retirement System's Regeneron Pharmaceuticals position peaked at $542M in Q1 2022.
- 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on California Public Employees Retirement System's 13F filing for Q2 2026, filed 14 Aug 2026.